Dementia is having a crippling effect on the NHS and government must act now, says Alzheimer’s Research UK, as the charity reveals the cost of the condition on hospitals across England has doubled over the past decade, with 90% of these costs coming from emergency admissions. The figures reveal major pressures on the hospital system even before the impact of COVID-19 – and the charity argues that without life-changing dementia treatments, these pressures will continue to grow.
The UK’s leading dementia research charity has highlighted the impact of dementia on hospitals with a new interactive tool. Alzheimer’s Research UK hopes the new tool will put a spotlight on the desperate need for more research into the condition, to bring about life-changing treatments sooner and protect people from the distress of unnecessary hospital stays.
The figures show that dementia continues to have huge implications for the NHS, with the addition of COVID-19 exacerbating existing challenges for the health service, people living with dementia and their families. According to the Office of National Statistics (ONS); dementia was the most common main pre-existing medical condition among COVID-19 deaths between March and June this year, with a quarter of all COVID-19 deaths linked to dementia during this period. With national attention focused on the need to protect the hospital system, Alzheimer’s Research UK argues that the government needs a renewed focus on addressing the pressures from dementia including more investment in dementia research to find new treatments for the condition.
To create the tool, Alzheimer’s Research UK commissioned a healthcare intelligence agency to provide Hospital Episode Statistic (HES) data for people aged over 65 with dementia and those without. The charity’s analysis has revealed:
- The cost of dementia on hospitals has increased from £1.2bn (2010/11) to £2.7bn (2017/18).
- The number of people being admitted to hospital with dementia increased by 93% from 210,000 (2010/11) to 405,000 (2017/18).
- The number of hospital bed days for people living with dementia increased from 6.3m (2010/11) to 9.4m (2017/18).
- Stays in hospital due to dementia rose 180%, from 345,000 to 975,000.
- In 2017, people with dementia had a significantly higher proportion of emergency admissions (77%), compared to those without (34%).
- For patients with dementia, 90% of the total costs for the NHS are in emergency admissions, this is compared to 60% for patients without dementia.
- Underlying causes of admission for people with dementia included admissions for potentially preventable conditions such as pneumonia, sepsis, urinary system disorders, and leg fractures.
Alzheimer’s Research UK’s data dashboard gives people the opportunity to see the impact of dementia on the Clinical Commissioning Groups (CCGs) where they live. It offers insights into people’s hospital experiences, including the number of times people have been admitted and how long they spent in hospital.
The number of people living with dementia is expected to rise to 1m in just three years, the same year that dementia is projected to cost our economy £30bn. The charity hopes its findings will prompt government to deliver on its pledge to double dementia research funding, to save the NHS from the pressures caused by the lack of life-changing treatments for the condition.
Prof Jonathan Schott, Chief Medical Officer at Alzheimer’s Research UK and Professor of Neurology at the UCL Queen Square Institute of Neurology, said: “The cost of dementia on the UK hospital system is increasing at an alarming rate. These latest findings show the effect that the rising tide of dementia was having on our NHS even before the huge additional pressures associated with the current pandemic. Hospital stays are not just costly but have profound impacts on individuals with dementia and their loved ones, and are associated with a higher risk of death. It is therefore vital that we do everything possible to keep people healthy and out of hospital when at all possible.
There are currently no treatments that have been proven to alter the course of the major forms of dementia. Now more than ever we need to invest in research which is the only way we will make the breakthroughs we so desperately need. COVID-19 is having a catastrophic impact on dementia research, and critical progress is at stake if we don’t invest now. Government must deliver on its promise to double dementia research funding to over £160m a year, so we can bring about the life-changing treatments we desperately need both to protect our hospitals and those affected by dementia.”